RecruitingNCT06133374

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples


Sponsor

University of Calgary

Enrollment

130 participants

Start Date

Jul 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to determine whether results from a fine needle biopsy are the same as results from a larger sample that is acquired from the surgical pathology using the Thyroid GuidePx® test in patients with papillary thyroid carcinoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines whether the molecular (genetic) profile of a thyroid cancer tumor found on a needle biopsy (a small sample taken through the skin) matches the profile found in the surgical specimen after the thyroid is removed. This can help validate whether biopsy-based genetic testing is accurate enough to guide treatment decisions before surgery. **You may be eligible if...** - You are 18 or older - You have been diagnosed with papillary thyroid cancer (or a thyroid nodule with positive genetic markers) based on a fine needle biopsy - Your tumor is larger than 1 cm on imaging - You are scheduled for and able to undergo thyroid surgery **You may NOT be eligible if...** - You have a history of radiation to the neck - You are unwilling or unable to have a fine needle biopsy - You are not willing to undergo thyroid surgery - Your final surgery result does not show papillary thyroid cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Foothills Medical Centre

Calgary, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06133374


Related Trials